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Stem cells,  the earliest precursor cells that populate the lymphoid and hemopoietic 
systems in mammals, have a very high proliferative capacity. They can be transplanted 
by  intravenous  injections  of single-cell  suspensions.  Therefore,  they  are  useful  in 
determining whether somatic cells  are timed to age as a  result  of intrinsic limits on 
proliferative capacity. Such a prediction has been made after studies with fibroblasts 
in vitro (1, 2). In many experiments, hemopoietic and lymphoid stem cells  from old 
and young donors have repopulated recipients  equally well,  implying that  changes 
with age are not intrinsic  (3-8).  In other cases,  especially with lymphoid stem cells, 
results have suggested intrinsic deficiencies (9-15). Gozes, et al.  (16) recently reported 
that  cellular  immune responses by old stem cells  declined after 8  too, although the 
hemopoietic  cells  functioned  normally.  Since  lymphoid  and  hemopoietic  cells  are 
progeny of the same precursor (17, 18), these findings suggest that stem cell regulation 
may alter with  age.  Recent results  by Tyan (19)  showing that  both the helper and 
suppressor functions of Thy-l-sensitive regulatory cells change with age reinforce this 
suggestion. In other experiments,  marrow cells  from old animals  failed  to maintain 
normal  hemopoiesis  and  lymphopoiesis  (15),  but  marrow  responses  to  stress  were 
normal (20). 
If there is no difference in proliferative capacity between stem cells  from old and 
young animals, then it is possible that such cells do not age. The experiments reported 
in this paper were designed to test stem cell function by mixing stem cells  from old, 
young, or fetal donors with a standard dose of young competitor cells,  and injecting 
the mixtures into stem cell-depleted recipients.  Under these conditions, the two cell 
types  in  the  mixture,  each  producing distinguishable  hemoglobins, compete to  re- 
populate the host  (8, 21,  22).  After the recipient  is fully repopulated, percentages of 
donor cells  are  estimated  by measuring the  percentage  of donor type hemoglobin. 
This is proportional to the percentage of erythropoietic stem cells  of the donor type 
(22).  To  test  stem  cell  proliferating  abilities  more  rigorously,  we  stimulated  an 
additional  round  of rapid  repopulation  by sublethal  whole body irradiation.  This 
treatment  causes  a  surprisingly  severe  deleterious  effect  on  stem  cell  repopulating 
abilities (8). The relative repopulating abilities of old, young, and fetal stem cells were 
again determined by the percentage of donor type hemoglobin in the recipients. 
Other workers have reported that stem cells from fetal liver have higher proliferative 
capacities (23) and better competitive repopulating abilities  (24) than stem cells  from 
marrow. While this seems plausible, it is not what would be expected if stern cells had 
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infinite proliferative capacities. In neither of the studies (23, 24) were the differentiated 
cells produced by the fetal donor's stem cells identified. The present study shows the 
contribution to the erythrocyte pool of stem  cells from  equal  doses of old marrow, 
young marrow, and fetal liver. When B6 donors were used, old stem cells repopulated 
erythroid compartments more effectively than young or fetal stem ceils. This remained 
true  after  500  rad  irradiation,  and  in  nonirradiated  W-anemic  recipients.  When 
B6CBAF1  donors were  used, stem  cells from  old marrow  were  more  effective than 
those from young. However young stem cells were more effective when CBA marrow 
was  tested. These data suggest that  aging is not  intrinsic in stem cells, and  genetic 
factors appear to determine how their regulation is affected by aging. 
Materials  and  Methods 
Mice.  C57BL/6J  (B6), CBA/CaJ (CBA), CBA/HT6J (CBAT6), the F1 hybrid of WB/ReJ 
and B6 (WBB6F1), B6CBAF1, and B6CBAT6Fx hybrid mice were bred and maintained at The 
Jackson Laboratory, which is fully accredited by the American Association for Accreditation of 
Laboratory Animal Care. WB-IV/+ X B6-W°/+ parents were used to produce WBB6F1-IV/ 
W ° mice, genetically anemic mutants with defective erythropoietic stem cell lines (25).  Some 
mice of genotypes WBB6Fx-W/+ or Wo/+ were thymectomized at 4-6 wk of age by sucking 
the thymus into a glass pipette and rapidly closing the incision. The thymectomized mice were 
immunologically crippled by lethal irradiation, and were used as recipients. 
Irradiation.  All recipients, except the W/W ° mice, were lethally irradiated with 1,100-1,200 
rad in a Shepherd Mark I Gamma Irradiator with a Cs-137 source at dose rates of 150 rad/min 
15-18 h before marrow was transplanted. For sublethal irradiation (500-600 rad), donors were 
treated 90-120 d before they were used. Recipients of mixtures were checked 77-106 d after the 
sublethal irradiation. 
Transplantation and Competitive Repopulation Assay.  Marrow cell suspensions were prepared by 
rinsing both femurs and tibias of each donor with a balanced salt solution buffered by Hepes 
to a  pH of 7.4  (8).  Livers from  15-16-d fetal mice were minced in the same type of media. 
Clumps of cells were dissociated by hydrostatic pressure as they were gently expelled through 
a  1-ml disposable syringe pressed against the bottom of a  4-ml sterile plastic culture tube. 
Suspensions were filtered through 100-mesh nylon cloth, and cells were counted using a Coulter 
model ZBI electronic cell counter (Coulter Electronics Inc., Hialeah, FL). Appropriate numbers 
of cells from  each  donor were  mixed with equal  numbers  of marrow  cells from  a  pool of 
genetically distinguishable competitors. Mixtures were injected intravenously into the appro- 
priate recipients. 
Erythropoietic stem  cell  proliferation was  analyzed using  donors  and  competitors with 
electrophoretically  separable hemoglobins (22). B6 mice have azfl2* (single) hemoglobin, whereas 
dmaj  dmm  WB and CBA mice have a~fl2  "  and t~z~2  "  (diffuse) hemoglobins. There is little or no hybrid 
resistance from WBBfFI animals against B6 cells, or from B6CBAF1 animals against CBA cells 
(26).  Chromosome markers were identified in proliferating cells using standard techniques (6). 
To identify specific cell types, T and B ceils from spleens were stimulated to proliferate in vitro 
by phytohemagglutinin (PHA) and Escherichia coli lipopolysaccharide (LPS), respectively, while 
marrow ceils were stimulated in vivo by bleeding (6, 8, 21). 
Results 
In the first experiment, host hemoglobins were quantitated ~90 d  after donor and 
competitor stem cells were  injected into lethally irradiated WBB6F1  hosts.  B6  stem 
cell donors  were  either old marrow,  young marrow,  or  fetal liver; each  was  mixed 
with young WBB6F1 marrow competitor stem cells. The B6 cells synthesize only single 
hemoglobin, whereas the WBB6F1 cells produce equal quantities of single and diffuse 
hemoglobin. Thus the percentage of hemoglobin produced by B6 cells may be readily 
calculated  from  the  measured  percentages  of  single  and  diffuse  hemoglobin  as 1498  LONG-TERM  ERYTHROPOIETIC  REPOPULATION 
previously described  (22);  data are given as the percentage of B6 donor hemoglobin. 
Descendants of stem cells from old B6 donors produced  25% more hemoglobin than 
those from young donors and 31% more than those from  15-16-d fetal livers (Table 
I). 
The  recipients  were  sublethally  irradiated  with  500  rad  after  120  d,  and  the 
hemoglobins were checked  77  d  thereafter.  Recovery from the sublethal  irradiation 
requires a second round of rapid stem cell proliferation; this might show defects in the 
proliferative capacity of old stem cells. However, these cells retained their advantage. 
Descendants of old stem cells produced 15% more B6 hemoglobin than those of young 
stem cells,  and 43%  more B6  hemoglobin than  those of fetal ceils  (Table  I). After 
sublethal irradiation, the percentages of B6 hemoglobin fell, regardless of whether the 
donor  stem  cells  were  from  fetal  liver,  young  marrow,  or  old  marrow  (Table  I). 
Perhaps this occurred because B6 stem cells from all three sources were slightly more 
radiosensitive than the WBB6F1 competitor stem cells. 
A  single dose of sublethal  irradiation  severely damages competitive repopulating 
ability (8), as is illustrated in Fig.  1. After recovering for 90 d from 550 rad, stem cells 
from the sublethally irradiated  donor produced  undetectable  amounts  (2  +  1%)  of 
the hemoglobin when mixed with unirradiated  competitor cells, whereas stem cells 
from  an  untreated  donor  produced  42  +  4%  of the  hemoglobin  (Fig.  1).  When 
chromosome  markers  were  used  to  distinguish  donor  and  competitor,  sublethal 
irradiation  120  d  before the assay reduced the ability of stem cells to produce T, B, 
and erythroid cell precursors three- to sevenfold; these responded to PHA, LPS, and 
severe bleeding,  respectively (Fig.  1).  These experiments suggest that  recovery from 
sublethal irradiation  is a  stress that should uncover subtle defects in stem cells from 
aging donors. As shown in Table I, no such defect was found. 
A  second experiment was performed to test the effect of using immune competent 
recipients. WBB6F1-W/W v recipients can be repopulated without irradiation, main- 
taining  fully functional  lymphoid  systems during  repopulation  (25).  B6  stem ceils 
from old marrow, young marrow, or fetal liver donors were each mixed with identical 
doses of young marrow from WBB6FI competitors as in the first experiment. Mixtures 
were  injected  into  WBB6Fa-W/W ~ recipients,  and  into  WBB6FrW/+  or  W~/+ 
TABLE  I 
Effect of Stem Cell Age on Eo~thropoietic Repopulating Ability in Serially Irradiated Recipients 
Recipient Hb measured*  Percentage Hb~ of B6 donor type: 
Days after 
cell  injection  Recipient treatment  Fetal liver  Young marrow  Old marrow 
80-100  Lethal irradiation day -  1  53 ±  3 (7)  59 +  8  (8) 
187-207  Lethal  irradiation  day  -1  plus  21  ±  3 (7)  49 ±  10 (7) 
500 rad day 110-130 
84 ±  4  (8) 
64 ± 8 (8) 
* Recipient  hemoglobins were  initially  checked  80-100  d  after  male WBB6FI  recipients  were  lethally 
irradiated and grafted with a  mixture of 2.5  X  106 cells  from the appropriate B6 donor plus 1.0  ×  106 
marrow cells pooled from 6-mo-old WBB6F1  +/+  competitors. Recipients were given an additional 500 
rad gamma (Cs-137)  irradiation 30 d later (at  110-130  d), and hemoglobins were checked a second time 
in 77 d  (187-207 d after mixtures were transplanted). 
~: Hemoglobin (Hb) percentages are given as mean +  SE (number of donors with a mean of 3.4 recipients 
per donor). Liver was taken from 15-16-d fetuses;  young marrow donors averaged 4.1 mo and old marrow 
donors 26.4 mo of age. All donors were B6 mice. DAVID  E.  HARRISON 
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FIO.  1.  The effect  of sublethal irradiation on stem cell  competitive repopulating ability.  Donors 
were tested  in the competitive repopulation assay either without pretreatment or after receiving 
550-600  rad gamma (Cs-137)  90-120 d  previously. Hemoglobin markers were used to distinguish 
erythrocytes  produced  by  stem  cells  from  8-too-old  CBAT6  donors  and  those  from  5-mo-old 
B6CBAF~  competitors in the left hand panel;  mixtures of 1 ×  106 donor and competitor marrow 
cells  were given to each lethally irradiated  B6CBAT6F~  recipient  90  d  before hemoglobins were 
assayed. Chromosome markers were used to distinguish mitoses stimulated by PHA or LPS with 
spleen cells  in vitro or by bleeding with marrow cell  in vlvo in the next three panels. Donors were 
6-mo-old  B6CBAT6F1  mice,  whereas competitors were  5-too-old  B6CBAF1  mice.  Each  lethally 
irradiated B6CBAF~ recipient was given 3 X 106 donor and competitor marrow cells 75-150 d before 
its cells were stimulated for the assay, and an average of 48 mitoses were scored per recipient. Data 
bars show mean =t=  SE;  numbers of recipients are given by the top of each bar.  In each panel, 
percentages of donor type were significantly lower after sublethal irradiation  (P <  0.05,  Student- 
Newman-Keuls multiple range test). 
TABLE  II 
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Recipient Hb measured*  Percentage Hb~: of B6 donor type: 
Days after 
cell  injection  Recipient treatment  Fetal liver  Young marrow  Old marrow 
82-98  Thymectomized, lethal  55 :t: 6 (2)  29 :t: 5 (5)  75 +  8 (6) 
irradiated day -  1 
82-98  Intact  W~ W ~  43 +  2 (2)  31  :l: 5 (5)  52 :l: 3 (6) 
* Recipient hemoglobins were initially checked 82-98 d after male WBB6F1 recipients were given a mixture 
of 2.5  ×  10  s cells  from the appropriate B6 donor plus  1.0  ×  106 marrow cells  pooled from 4-5-mo-old 
WBB6Fx  +/+  competitors. Thymus glands had been removed from the thymectomized recipients at 5- 
6 wk of age, so that T  cells  could not regenerate after lethal  irradiation.  Intact male WBB6Fx-W/W  ~ 
recipients were given identical cell  mixtures, but were not irradiated. 
Hemoglobin (Hb) percentages are given as mean +  SE (number of donors with a mean of 4.5 recipients 
per donor). Liver was taken from 15-16-d fetuses;  young marrow donors averaged 4.3 mo and old marrow 
donors 25.7 mo of age. All donors were B6 mice. 
recipients  immunologically crippled by thymectomy followed by lethal  irradiation. 
The results are presented in Table II. Again, stem cells from old B6 mice repopulated 
most effectively, with  their  descendants  producing  46%  more B6  hemoglobin than 
young stem cells and 20% more than fetal liver in immunologically crippled animals. 
Old  cells produced  21%  more B6  hemoglobin than  young stem cells and 9% more 
than fetal liver in immunologically intact  IV/W v recipients. 
Some of the recipients described in Table II were sublethally irradiated 90 d  after 1500  LONG-TERM  ERYTHROPOIETIC  REPOPULATION 
TABLE III 
Serial Irradiation of T  Cell-deficient and Intact Recipients 
Recipient Hb measured* 
Days after 
cell injec- 
tion 
Recipient treatment 
Percentage Hb:~  of B6 donor 
type: 
Young marrow  Old marrow 
82  Thymectomized, lethal  32 + 5 (3)  87 ± 2 (3) 
irradiated day -  1 
82  Intact  W/W v  36 + 4 (3)  55 + 5 (3) 
196  Thymectomized, lethal  37 ± 6 (3)  81 ± 7 (3) 
irradiated day -1 plus 500 
rad day 90 
196  Intact  W/W ~ plus 500 rad day  38 ± 6 (3)  60 ± 4 (3) 
90 
* As in Table II, except that 8 d after the first hemoglobin samples were taken, all 
recipients were given 500 rad of gamma (Cs-137) irradiation. The second hemoglo- 
bin samples were taken 106 d afterwards. 
:~ As in Table II, except an average of 4.6 recipients per donor, and old and young 
donors were 25.2 and 3.8 mo old, respectively. Some of these data are included in 
Table II. 
injection with donor cells. Old  B6  stem cells continued to  outperform young ones, 
with their descendants producing 55 and 44% more B6 hemoglobin than cells from 
young donors in immunologically  crippled recipients before and 106 d after sublethal 
irradiation, respectively (Table III). They produced  19  and 22%  more hemoglobin 
than young stem cells in immunologically  intact W~ W v recipients after the same time 
periods. 
Mice  of other  genotypes were  also  tested  to  determine the  effects  of donor age. 
Marrow cells from old and young B6CBAF1 hybrids were mixed with portions from 
a  pool of CBA competitor marrow cells, and mixtures were given to  the  following 
types of lethally irradiated B6CBAF1 recipients: old given an infant thymus, young 
given an infant thymus, and young. Infant thymuses were given to improve immune 
responses in the old recipients (27). 1 In these experiments, the CBA cells synthesize 
only diffuse hemoglobin, whereas  the  B6CBAF1  cells  produce  equal  quantities of 
single and  diffuse  hemoglobin. Thus  the  percentage  of hemoglobin  produced  by 
B6CBAF1 or CBA cells may be readily calculated from the measured percentages of 
single and diffuse hemoglobins, as previously described  (22).  Data are given as  the 
percentage of donor hemoglobin. The amounts of single and diffuse hemoglobin were 
measured  after  ~87  d,  and  rechecked  after  ~195  d  in  these  recipients;  sublethal 
irradiation was not used. Neither recipient age nor the presence of an infant thymus 
affected  the relative repopulating abilities of stem cells from old and young donors 
(Table IV).  With B6CBAF1  donors,  descendants of old  stem  cells produced  ~20% 
more hemoglobin than descendants of young stem cells. However, with CBA donors, 
old stem cells produced ~20% less hemoglobin than young ones (Table IV). 
1  Astle, C.  M., and D.  E.  Harrison. Beneficial effects of young but not old stem cells on immune 
responses of aged mice: studies at the cellular level. Manuscript submitted for publication. DAVID E.  HARRISON  1501 
TABLE  IV 
Effect of Stem Cell Age on Erythropoietic Repopulating Ability In OM and Young Recipients 
Donor  Competed against 
Percent donor* hemoglobin in:  Time in 
recipi-  Old + IT re-  Young + IT re-  Young recipi- 
ent~  cipients§  cipients§  ents§ 
Old B6CBAF~  Young CBA  1  77 4- 7 (3)  75 4- 8  (4)  83 4- 4  (4) 
2  77 4- 4 (3)  72 4- 12 (3)  88 4- 7  (3) 
Young B6CBAF~  Young CBA  1  56 4- 3 (3)  50 ztz 6  (4)  50 4- 11 (4) 
2  68 4-4(3)  70+6  (3)  63 4- 11 (3) 
Old CBA  Young B6CBAF1  1  26 4- 5  (4)  17 zlz 2  (3)  16 4- 3  (4) 
2  7+2(3)  84-2  (3)  94-2  (4) 
Young CBA  Young B6CBAF~  1  40 4- 4 (4)  44 4- 6  (4)  44 4- 3  (4) 
2  224-8(3)  224-3  (4)  254-3  (4) 
* Old donors were 811-938 d old and young donors were 91-147 d old, while old recipients were 610-680 
d old and young recipients 80-100 d old when cells were injected.  E~ual numbers (1 ×  10  ~) of marrow 
cells from old and young B6CBAF~ donors were mixed with 1 x  10  marrow ceils from pooled young 
CBA competitors (top four lines); the same cell numbers were used with old and young CBA donors and 
pooled B6CBAFI competitors (bottom four lines). 
~: Time since grafting is given as 1 (the first hemoglobin analysis after 87 +  17 d) and 2 (the second analysis 
after 195 4- 30 d). 
§ All recipients were  lethally irradiated.  Those  designated  IT were  given infant  O-3-d-old)  thymus 
transplants under the kidney capsule (27)  a 1-5 d after lethal irradiation and marrow transplantation. 
Results are given as mean 4- SE (number of donors)  for the percentages  of donor hemoglobin. Usually 
two recipients were averaged for each donor value. 
Discussion 
This study demonstrates that  long-term erythropoietic  stem cell functions do not 
necessarily  decline  with  age.  In  fact,  descendants  of stem  ceils  from  old  B6  mice 
consistently  produced  erythrocytes  more  effectively  than  those  from  stem  cells  of 
young B6 or fetal B6 mice, when competing against young WBB6F1 stem cells (Tables 
I-III).  The  descendants  of  stem  cells  from  old  B6CBAFx  donors  also  produced 
erythrocytes more effectively than those from young B6CBAF1 donors in competition 
with young CBA stem cells. On  the other hand, stem cells from old CBA mice were 
less effective than those from young CBA mice (Table IV). These results suggest that 
erythropoietic stem cells maintain their proliferative abilities unchanged  throughout 
the lifespan, and that the differences shown in this report result from alterations with 
age in regulatory functions. 
Competitive  repopulating  abilities  are  affected  by  both  long-  and  short-term 
differences  in  the  ability  of  stem  cells  to  proliferate  and  differentiate  in  lethally 
irradiated recipients. Maximal  functional abilities are tested that allow subtle differ- 
ences between  stem  cell  types  to  be  demonstrated.  For example,  using competitive 
repopulation techniques, 5- to 20-fold differences are demonstrated between repopu- 
lating abilities of untransplanted stem cells and those transplanted a  single time (6, 8, 
21, 28). 
The studies described in Tables I  and III test proliferation and differentiation even 
more rigorously, since the ceils must recover from sublethal irradiation after repopu- 
lating the recipient; this recovery requires another burst of proliferation and  differ- 1502  LONG-TERM  ERYTHROPOIETIC  REPOPULATION 
entiation. Fig. 1 shows that sublethal irradiation greatly reduces stem cell repopulating 
abilities  (8).  Descendants of old stem cells should recover less well if they have any 
subtle  functional  defects. Therefore,  the  fact  that  old  B6  stem cells maintain  their 
advantage over young or fetal stem cells after sublethal irradiation suggests that the 
proliferative capacity of B6 stem cells is unimpaired with age. 
The advantage of old erythropoietic stem cells in two of three genotypes tested is 
unexpected.  Possibly regulatory changes with age in old B6 donors allow their stem 
cells to proliferate especially rapidly after transplantation.  If the old stem cells have 
an initial advantage, their competitor cells may never be able catch up. The advantage 
of old B6 cells is reduced in immunologically intact  IV~ W v recipients compared with 
immunologically crippled thymectomized and lethally irradiated  recipients  (Tables 
II and III). Old marrow may contain higher concentrations of graft-vs.-host (GVH)- 
reactive cells that react against the WBB6F1 competitors, reducing their repopulating 
ability. GVH reactions do not harm W-anemic recipients (29), probably because their 
intact lymphoid cells protect them. This effect would also protect WBB6F1 competitor 
cells against GVH reactions. It is also possible that the advantage of old stem cells is 
reduced  in  immunologically  intact  W/W  v  recipients  because  abnormalities  that 
develop in erythropoid committed stem cells with age are eliminated by the immune 
system. Nevertheless, even in these recipients, erythropoietic precursor cells from old 
donors produce more hemoglobin than those from young or fetal liver donors when 
competing against the same competitors (Table II), and this advantage is maintained 
after recovery from sublethal irradiation  (Table III). Results with our system would 
be misleading if erythrocytes produced by descendants of old stem cells had extended 
lifespans in the circulation;  this, however, seems extremely unlikely. 
Young adult marrow repopulated as well as fetal liver when seven to eight donors 
were compared  (Table I), though  not  in a  second experiment, using only two fetal 
donors  (Table II). It repopulated better after sublethal  irradiation  (Table I). These 
results  seem  to  conflict  with  previous  reports  (24)  that  stem  cells  from  fetal  liver 
repopulate 5-10 times better than those from adult marrow when equal numbers of 
cells are mixed, and recipients are studied  after >50  d.  Possibly, the specific mouse 
genotype tested is important; we used B6 mice, whereas Micklem and his colleagues 
(24)  compared fetal and adult cells from CBA mice. Another possible explanation is 
that they measured all proliferating cells, while we measured erythropoietic stern cell 
function specifically. 
The most likely explanation for our results is that erythropoietic stem cells do not 
change their repopulating capacities during the lifespan of the mouse. The differences 
observed between young, old, and fetal cells probably result from regulatory changes 
with age. These regulatory changes give stem cells from old B6 or B6CBAF1 mice a 
temporary advantage on  transplantation,  whereas changes  with  age in  CBA  mice 
have the opposite effect. Because the stem cells all have the same intrinsic repopulating 
abilities,  the  competitor  cells  are  never  able  to  overcome  this  early  advantage, 
although it probably lasts for only a  short time. This explanation  implies that stem 
cells are not affected by aging. 
Summary 
It is possible that erythropoietic stem cells do not age. This would mean that stem 
cells from old donors can function as well as those from young or fetal donors.  The DAVID E.  HARRISON  1503 
competitive repopulation assay has been used to test long-term stem cell function by 
directly comparing how well competing stem cells repopulate a recipient and produce 
differentiated  cell types.  C57BL/6J  (B6)  mice were used as donors, while recipients 
and competitors were WBB6F1 hybrids with genetically distinguishable  hemoglobin. 
Lethally irradiated young WBB6Fa recipients were given a  mixture of 2.5 ×  106 cells 
from B6 old marrow, young marrow, or fetal liver donors; each recipient also received 
a  standard dose of 1 ×  106 marrow cells from a  pool of young WBB6F1 competitors. 
Surprisingly,  the old marrow cells competed the best in repopulating the recipients. 
This  pattern  was  maintained  even  after  recovery  from  sublethal  irradiation,  a 
treatment that severely stresses stem cells. This stress was demonstrated when sublethal 
irradiation caused a  20-fold decline in repopulating ability measured using hemoglo- 
bin markers,  and a  3- to 7-fold decline using chromosome markers.  Stem cells from 
old marrow competed better  than  young or fetal  cells  in similar  experiments  using 
immunologically crippled recipients or using unirradiated  IV/W ° recipients that are 
immunologically intact. In both types of recipients, the advantage of old marrow cells 
again persisted after recovery from sublethal irradiation. Other genotypes were tested, 
and marrow cells from old B6CBAF1 donors competed better than those from young 
donors of that genotype. However, marrow cells from young CBA donors completed 
better  than  those  from old  CBA donors.  These  results  support  the  hypothesis  that 
stem cells do not age, and suggest  that  regulatory changes with  age promote rapid 
stem cell repopulation in B6 and B6CBAF1 mice, but inhibit it in CBA mice. 
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